Markel Insurance SE branch approved in UK

RICHMOND, Va., Nov. 12, 2018 /PRNewswire/ -- Markel Corporation (NYSE: MKL) announced today that its German insurance company, Markel Insurance SE (MISE), has received regulatory approval to operate a branch office in the UK.  

MISE was established to meet the insurance needs of clients located or with risk exposures in the European Economic Area (EEA) following Brexit and the UK branch will support brokers and policyholders in underwriting EEA exposures through London.

MISE already has branches authorized in Spain and the Netherlands.

About Markel International

Markel International is a subsidiary of Markel Corporation, a US-based holding company trading on the New York Stock Exchange (NYSE: MKL). Markel International writes insurance and reinsurance business through six divisions and through offices across the UK, Europe, Canada, Latin America and Asia Pacific. Markel International's insuring entities include Syndicate 3000, Markel International Insurance Company Limited, Markel Insurance SE., Markel Resseguradora do Brasil S.A. and Markel Seguradora do Brasil S.A. Markel International also manages the business of Abbey Protection Group which provides legal and professional fees insurance cover as well as legal and tax consultancy services. For more information please visit us at www.markelinternational.com

About Markel Corporation
Markel Corporation is a diverse financial holding company serving a variety of niche markets. The Company's principal business markets and underwrites specialty insurance products. In each of the Company's businesses, it seeks to provide quality products and excellent customer service so that it can be a market leader. The financial goals of the Company are to earn consistent underwriting and operating profits and superior investment returns to build shareholder value. Visit Markel Corporation on the web at markelcorp.com.

View original content to download multimedia:http://www.prnewswire.com/news-releases/markel-insurance-se-branch-approved-in-uk-300747819.html

SOURCE Markel Corporation